Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
94.50    2.30 (2.49%)
Bid:
94.10
Ask:
94.40
Spread: 0.30 (0.319%)
Market Cap: £348.08m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

Board Changes

14 Jan 2025 07:00

RNS Number : 1558T
C&C Group Plc
14 January 2025
 

This announcement contains inside information.

C&C Group plc

("C&C" or "the Group")

Board Changes

C&C Group plc, the vertically integrated premium branded drinks group and leading drinks distributor to the UK and Ireland hospitality sectors, announces the following Board changes:

John Gibney has informed the Board of his intention to step down as a Non-Executive Director of the Group, with effect from 13 January 2025. John has worked closely with Andrew Andrea, Chief Financial and Transformation Officer, to deliver substantial improvement in the Group's risk and internal control processes. As such, he now feels this is an appropriate time for him to step down and the new leadership team to continue this work.

John will be succeeded by Feargal O'Rourke, Non-Executive Director, as Chair of the Audit Committee. During a 37 year career with PwC, latterly serving as Managing Partner in Ireland until his retirement from the professional services firm in October 2023, Feargal advised Irish and international companies on a broad range of financial issues including investment, financing and business structuring. In January 2024, he was appointed by Ireland's Minister for Enterprise, Trade and Employment as Chair of IDA Ireland and is also Chair of the Institute of International and European Affairs, the Irish based international think tank.

 

In addition, Mark Chilton, Company Secretary and Group General Counsel, has notified the Board that he will retire on 31 August 2025. Gillian Kyle, currently Deputy Company Secretary, will take on the role of Company Secretary with effect from the close of the 2025 AGM. A highly experienced company secretariat professional, Gillian joined C&C in 2023 from The Weir Group PLC where she was Deputy Company Secretary (2015-2023), having previously held a similar role at Aggreko plc from 2008-2015.

As previously announced, Ralph Findlay will return to the position of Non-Executive Chair as of 1 March 2025 following a short period of transition after Roger White joins the business as Chief Executive Officer on 20 January 2025. Ralph will also resume the role of Chair of the Nomination Committee at that time.

Ralph Findlay, Chair and CEO of C&C Group plc, commented:

"On behalf of the Company and the Board, I would like to thank John for his significant contribution to C&C during his tenure with the business. We wish John every success for the future and are delighted to welcome Feargal to the role of Audit Committee Chair.

"I would also like to thank Mark for his dedication and commitment to the business over the last six years with the Group. We wish him well in his retirement later this year and look forward to Gillian supporting the Board as Company Secretary."

This announcement has been made in accordance with the requirements of Listing Rule 6.4.6 and there is no further information to be disclosed under the requirements of Listing Rule 6.4.8.

14 January 2025

 

ENQUIRIES

C&C Group plc

Email: investor.relations@candcgroup.ie

Instinctif Partners T: +44 (0)20 7457 2020

Justine Warren/ Tim Pearson/ Amelia Thorn

Email: candccapmkts@instinctif.com

 

Irish Media

FTI Consulting

Jonathan Neilan / Paddy Berkery / Niamh O'Brien

Tel: +353 86 231 4135 / +353 86 602 5988 / +353 87 707 8379

Email: C&CGroup@fticonsulting.com

 

About C&C Group plc

C&C Group plc is a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits, and soft drinks across the UK and Ireland.

· C&C Group's portfolio of owned/exclusive brands include Bulmers, the leading Irish cider brand and Tennent's, the leading Scottish beer brand; as well as a range of fast-growing, premium and craft ciders and beers, such as Heverlee, Menabrea, Five Lamps and Orchard Pig. C&C exports its Magners and Tennent's brands to over 40 countries worldwide.

· C&C Group has owned brand and contract manufacturing/packing operations in Co.Tipperary, Ireland and Glasgow, Scotland.

· C&C is the No.1 drinks distributor to the UK and Ireland hospitality sectors. Operating through the Matthew Clark, Bibendum, Tennent's and Bulmers Ireland brands, the Group has a market leading range, scale and reach including an intimate understanding of the markets it serves. Together this provides a key route-to-market for major international beverage companies.

C&C Group plc is an Irish incorporated FTSE 250 company headquartered in Dublin and is listed on the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABRGDBDUBDGUX
Date   Source Headline
3rd Jun 20263:59 pmRNSHolding(s) in Company
2nd Jun 20265:19 pmRNSHolding(s) in Company
2nd Jun 202612:04 pmRNSHolding(s) in Company
1st Jun 20266:18 pmRNSTotal Voting Rights
28th May 20264:30 pmRNSHolding(s) in Company
28th May 202610:40 amRNSDirector/PDMR Shareholding
27th May 20264:43 pmRNSHolding(s) in Company
19th May 20263:54 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSFinal Results
8th May 20267:00 amRNSHolding(s) in Company
7th May 20265:28 pmRNSHolding(s) in Company
1st May 20264:28 pmRNSHolding(s) in Company
1st May 20264:25 pmRNSTotal Voting Rights
30th Apr 20264:49 pmRNSHolding(s) in Company
29th Apr 202611:14 amRNSHolding(s) in Company
29th Apr 202611:05 amRNSHolding(s) in Company
16th Apr 20264:37 pmRNSDirector/PDMR Shareholding
9th Apr 202612:12 pmRNSChief Financial Officer Update
1st Apr 202611:58 amRNSTotal Voting Rights
20th Mar 20265:42 pmRNSBoard Committee Membership Update
17th Mar 20263:30 pmRNSDirector/PDMR Shareholding
13th Mar 202612:33 pmRNSHolding(s) in Company
6th Mar 20261:15 pmRNSAcquisition of Innis & Gunn Brand
2nd Mar 202611:31 amRNSTotal Voting Rights
24th Feb 20261:09 pmRNSDirectorate change
18th Feb 202611:56 amRNSDirector/PDMR Shareholding
6th Feb 202612:34 pmRNSDirector/PDMR Shareholding
5th Feb 20267:02 amRNSAppointment of Chief Financial Officer
2nd Feb 202612:55 pmRNSTotal Voting Rights
23rd Jan 20267:00 amRNSFY26 Trading Update
19th Jan 20265:26 pmRNSDirector/PDMR Shareholding
9th Jan 20263:21 pmRNS2025 AGM Voting Update Statement
5th Jan 202611:40 amRNSTotal Voting Rights
23rd Dec 20255:53 pmRNSDirector/PDMR Shareholding
23rd Dec 20255:53 pmRNSDirector/PDMR Shareholding
22nd Dec 20251:12 pmRNSHolding(s) in Company
22nd Dec 20251:12 pmRNSHolding(s) in Company
17th Dec 202512:36 pmRNSDirector/PDMR Shareholding
17th Dec 202512:36 pmRNSDirector/PDMR Shareholding
10th Dec 20256:08 pmRNSHolding(s) in Company
1st Dec 20253:27 pmRNSTotal Voting Rights
26th Nov 202511:40 amRNSHolding(s) in Company
24th Nov 20254:38 pmRNSHolding(s) in Company
19th Nov 20254:46 pmRNSDirector/PDMR Shareholding
19th Nov 202510:45 amRNSDirector/PDMR Shareholding
18th Nov 20253:30 pmRNSDirector/PDMR Shareholding
14th Nov 202511:19 amRNSHolding(s) in Company
13th Nov 20251:45 pmRNSHolding(s) in Company
3rd Nov 20253:09 pmRNSTotal Voting Rights
28th Oct 20257:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.